Paratek Pharmaceuticals has recently finalized the acquisition of Optinose, a deal valued at nearly $330 million. This strategic move has significantly expanded Paratek's commercial product offerings, solidifying its position in…

Subscribe Now for Real-time Updates on the Latest Stories!
Find out how much you could earn with today’s money market account rates. The Federal Reserve cut its target rate…
 by Adam N. Michel, Cato at Liberty, June 25, 2025 Excerpt: The U.S. Department of Energy’s Energy Information Administration…
Unlock the White House Watch newsletter for free If you want to stay informed about what Trump's potential second term…
Warren Buffett, the legendary investor, is stepping back from his role at Berkshire Hathaway, but there is still plenty to…
Unlock the White House Watch newsletter for free Your guide to what Trump’s second term means for Washington, business, and…
In a recent program on CNBC, Jim Lebenthal from the CNBC Investment Committee shared his insights on why he is…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter.…
Chevron Corporation (NYSE:CVX) has recently been identified as one of the undervalued S&P 500 stocks to buy according to hedge…
Sign in to your account